Researchers analyzed brain proteomics from 625 Alzheimer's patients and found that mitochondrial protein loss is the dominant biochemical change in AD. Because glutathione (GSH) synthesis requires ATP, mitochondrial failure depletes GSH, removing the brain's key defense against ferroptosis — an iron-dependent form of cell death. Cellular experiments confirmed that ATP availability is rate-limiting for GSH production, and that mitochondrial inhibition increases or decreases ferroptosis depending on whether mitochondria are net GSH producers or consumers in that context. The study positions bioenergetic insufficiency as a direct physiological trigger for ferroptosis in AD, offering a mechanistic bridge between two long-recognized but previously unconnected disease hallmarks: energy deficit and oxidative stress.
